In vivo imaging of herpes simplex virus type 1 thymidine kinase gene expression: early kinetics of radiolabelled FIAU
- 1. Technische Univ. Muenchen (Germany). Nuklearmedizinische Klinik und Poliklinik
- 2. Inst. of Experimental Oncology, Technische Univ. Muenchen (Germany)
Description
The aim of our study was to examine the early kinetics of I*-FIAU and the possibility of utilising iodine-123-labelled FIAU for imaging of gene expression. CMS-5 fibrosarcoma cells were transduced in vitro with the retroviral vector STK containing the HSV1-tk gene. BALB/c mice were inoculated subcutaneously with HSV1-tk(+) and tk(-) cells into both flanks. FAU (2'-fluoro-2'-deoxy-1-β-d-arabinofuranosyluracil was radioiodinated (123I, 125I)) using the iodogen method. High-performance liquid chromatography purification resulted in high specific activity and radiochemical purity for both tracers ([123I]FIAU and [125I]FIAU). Biodistribution studies and gamma camera imaging were performed at 0.5, 1, 2 and 4 h p.i. In addition, the genomic DNA of the tumours was isolated for measurement of the activity accumulation resulting from the [125I]FIAU incorporation. Biodistribution studies 0.5 h p.i. showed tumour/blood and tumour/muscle ratios of 3.8 and 7.2, respectively, for the HSV1-tk(+) tumours, and 0.6 and 1.2, respectively, for negative control tumours. Fast renal elimination of the tracer from the body resulted in rapidly increasing tumour/blood and tumour/muscle ratios which reached values of 32 and 88 at 4 h p.i., respectively. Tracer clearance from blood was bi-exponential, with an initial half-life of 0.6 h followed by a half-life of 4.6 h. The tracer half-life in herpes simplex viral thymidine kinase-expressing tumours was 35.7 h. The highest activity accumulation (20.3%±5.7% ID/g) in HSV1-tk(+) tumours was observed 1 h p.i. At that time, about 46% of the total activity found in HSV1-tk(+) tumours was incorporated into genomic DNA. Planar gamma camera imaging showed a distinct tracer accumulation as early as 0.5 h p.i., with an increase in contrast over time. These results suggest that sufficient tumour/background ratios for in vivo imaging of HSV1-tk expression with [123I]FIAU are reached as early as 1 h p.i.(orig./MG) (orig.)
Additional details
Publishing Information
- Journal Title
- European Journal of Nuclear Medicine
- Journal Volume
- 27
- Journal Issue
- 3
- Journal Page Range
- p. 283-291
- ISSN
- 0340-6997
- CODEN
- EJNMD9
INIS
- Country of Publication
- Germany
- Country of Input or Organization
- Germany
- INIS RN
- 31021366
- Subject category
- S63: RADIATION, THERMAL, AND OTHER ENVIRONMENTAL POLLUTANT EFFECTS ON LIVING ORGANISMS AND BIOLOGICAL MATERIALS; S38: RADIATION CHEMISTRY, RADIOCHEMISTRY AND NUCLEAR CHEMISTRY;
- Descriptors DEI
- CARBON 14 COMPOUNDS; EXPERIMENTAL NEOPLASMS; FEASIBILITY STUDIES; GENES; HERPES SIMPLEX; IMAGES; IN VITRO; IN VIVO; IODINE 123; KINETICS; MICE; SUBSTRATES; THERAPY; TISSUE DISTRIBUTION; TUMOR CELLS; UPTAKE; URACILS; VIRUSES
- Descriptors DEC
- ANIMAL CELLS; ANIMALS; AZINES; BETA DECAY RADIOISOTOPES; CARBON COMPOUNDS; DISEASES; DISTRIBUTION; ELECTRON CAPTURE RADIOISOTOPES; HETEROCYCLIC COMPOUNDS; HOURS LIVING RADIOISOTOPES; HYDROXY COMPOUNDS; INFECTIOUS DISEASES; INTERMEDIATE MASS NUCLEI; IODINE ISOTOPES; ISOTOPES; LABELLED COMPOUNDS; MAMMALS; MEDICINE; MICROORGANISMS; NUCLEI; ODD-EVEN NUCLEI; ORGANIC COMPOUNDS; ORGANIC NITROGEN COMPOUNDS; PARASITES; PYRIMIDINES; RADIOISOTOPES; RODENTS; SKIN DISEASES; VERTEBRATES; VIRAL DISEASES
Optional Information
- Notes
- With 7 figs., 2 tabs.